中国骨伤
中國骨傷
중국골상
CHINA JOURNAL OF ORTHOPAEDICS AND TRAUMATOLOGY
2015年
5期
422-425
,共4页
陈献韬%谭旭仪%刘又文%张晓东%刘立云%贾宇东
陳獻韜%譚旭儀%劉又文%張曉東%劉立雲%賈宇東
진헌도%담욱의%류우문%장효동%류립운%가우동
减压术,外科%外科手术,微创性%骨移植%骨折固定术,内%股骨头坏死
減壓術,外科%外科手術,微創性%骨移植%骨摺固定術,內%股骨頭壞死
감압술,외과%외과수술,미창성%골이식%골절고정술,내%고골두배사
Decompression,surgical%Surgical procedures,minimally invasive%Bone transplantation%Fracture fix-ation,internal%Femur head necrosis
目的:观察微创减压植骨配合金属骨小梁重建系统植入治疗早中期股骨头坏死的应用效果,探讨早中期股骨头坏死保髋治疗方法。方法:2010年1月至2011年6月期间,采用微创减压植骨及金属骨小梁重建系统植入术治疗早中期股骨头坏死患者,共50例(62髋),男31例(40髋),女19例(22髋),发病年龄22~54岁,平均36.2岁;病程6~15个月,平均10.5个月;其中,激素性19例(23髋),酒精性25例(33髋),特发性6例(6髋);ARCO分期:Ⅰ期28髋,Ⅱ期34髋;术前均经影像学检查确诊为股骨头坏死。术后随访观察患者髋关节Harris评分及疗效,进行股骨头生存时间分析。结果:所有患者完成手术,手术时间30~85 min,术中出血量在50~220 ml。47例(58髋)获得随访,随访时间24~46个月,平均34.05个月。末次随访髋关节Harris评分较术前明显提升,差异有统计学意义(P<0.01)。ARCO分期中Ⅰ期患者与Ⅱ期在Harris评分、疗效及股骨头生存时间方面比较,差异有统计学意义(P<0.05)。结论:微创减压植骨配合金属骨小梁重建系统植入术在早中期股骨头坏死中的应用效果较好,能显著改善髋关节Harris评分,增加股骨头生存时间,推迟髋关节置换术,且ARCO分期中Ⅰ期效果较优。
目的:觀察微創減壓植骨配閤金屬骨小樑重建繫統植入治療早中期股骨頭壞死的應用效果,探討早中期股骨頭壞死保髖治療方法。方法:2010年1月至2011年6月期間,採用微創減壓植骨及金屬骨小樑重建繫統植入術治療早中期股骨頭壞死患者,共50例(62髖),男31例(40髖),女19例(22髖),髮病年齡22~54歲,平均36.2歲;病程6~15箇月,平均10.5箇月;其中,激素性19例(23髖),酒精性25例(33髖),特髮性6例(6髖);ARCO分期:Ⅰ期28髖,Ⅱ期34髖;術前均經影像學檢查確診為股骨頭壞死。術後隨訪觀察患者髖關節Harris評分及療效,進行股骨頭生存時間分析。結果:所有患者完成手術,手術時間30~85 min,術中齣血量在50~220 ml。47例(58髖)穫得隨訪,隨訪時間24~46箇月,平均34.05箇月。末次隨訪髖關節Harris評分較術前明顯提升,差異有統計學意義(P<0.01)。ARCO分期中Ⅰ期患者與Ⅱ期在Harris評分、療效及股骨頭生存時間方麵比較,差異有統計學意義(P<0.05)。結論:微創減壓植骨配閤金屬骨小樑重建繫統植入術在早中期股骨頭壞死中的應用效果較好,能顯著改善髖關節Harris評分,增加股骨頭生存時間,推遲髖關節置換術,且ARCO分期中Ⅰ期效果較優。
목적:관찰미창감압식골배합금속골소량중건계통식입치료조중기고골두배사적응용효과,탐토조중기고골두배사보관치료방법。방법:2010년1월지2011년6월기간,채용미창감압식골급금속골소량중건계통식입술치료조중기고골두배사환자,공50례(62관),남31례(40관),녀19례(22관),발병년령22~54세,평균36.2세;병정6~15개월,평균10.5개월;기중,격소성19례(23관),주정성25례(33관),특발성6례(6관);ARCO분기:Ⅰ기28관,Ⅱ기34관;술전균경영상학검사학진위고골두배사。술후수방관찰환자관관절Harris평분급료효,진행고골두생존시간분석。결과:소유환자완성수술,수술시간30~85 min,술중출혈량재50~220 ml。47례(58관)획득수방,수방시간24~46개월,평균34.05개월。말차수방관관절Harris평분교술전명현제승,차이유통계학의의(P<0.01)。ARCO분기중Ⅰ기환자여Ⅱ기재Harris평분、료효급고골두생존시간방면비교,차이유통계학의의(P<0.05)。결론:미창감압식골배합금속골소량중건계통식입술재조중기고골두배사중적응용효과교호,능현저개선관관절Harris평분,증가고골두생존시간,추지관관절치환술,차ARCO분기중Ⅰ기효과교우。
Objective:To observe the application effect of minimally invasive decompression,bone graft implantation and metal trabecular bone reconstruction system for early stage osteonecrosis of femoral head and discuss the treatment of hip salvage operation in early stage osteonecrosis of femoral head. Methods:From January 2010 to June 2011,50 patients(62 hips)which were osteonecrosis of femoral head of early stage,were treated with minimally invasive decompression,bone graft implantation and metal trabecular bone reconstruction system,including 31 males(40 hips),19 females(22 hip)with an av?erage age of 36.2 years old ranging from 22 to 54 years old. The course of disease was from 6 to 15 months(averaged 10.5 months). Among them,19 cases(23 hips)were steroid induced,25 cases(33 hips)were alcohol induced,6 cases(6 hips) were idiopathic;According to ARCO stage,28 hips were at stageⅠ,34 hips were at stageⅡ. All of them were diagnosed as femoral head necrosis by imaging examination before operation. Then each patient was followed to assess by Harris hip score , curative effect,and conduct the femoral head survival analysis during the postoperation. Results:All patients had finished op?eration,the operation time was between 30 and 85 min,intraoperative blood loss was 50 to 220 ml,and 47 cases(58 hips) were follow up from 24 to 46 months with an average of 34.05 months. As compared with preoperative,the Harris hip score at the last follow up was improved,the difference was statistically significant(P<0.01). The Harris hip score,curative effect and survival time of femoral head in ARCO stageⅠwas superior to these in ARCO StageⅡ,the difference was statistically signif?icant(P<0.05). Conclusion:Effect of minimally invasive decompression,bone graft implantation combine with the metal tra?becular bone reconstruction system for early stage osteonecrosis of femoral head was good,it could significantly improve the Harris hip score,increase the femoral head survival time,delay the hip replacement,and performance better in ARCO stageⅠ.